HCA: Apple Health (Medicaid) reimbursement options treating COVID-19 in uninsured individuals
Apple Health (Medicaid) reimbursement options treating COVID-19 in uninsured individuals
The Health Care Authority (HCA) sends you this notification to clarify reimbursement options when testing for and treating COVID-19 in uninsured patients. Specifically, we aim to answer frequently asked questions around the Health Resources & Services Administration (HRSA) portal, and Alien Emergency Medical (AEM).
We are also including some helpful resources for discussing the COVID-19 vaccine with clients / patients.
What is the HRSA COVID-19 Uninsured Program?
The HRSA COVID-19 Uninsured Program was established in February 2020 as a reimbursement program for providers that have performed tests and provided treatment, including vaccines to uninsured individuals on or after February 4, 2020.
Why would a provider choose reimbursement through the HRSA COVID-19 Uninsured Program instead of AEM?
The HRSA COVID-19 Uninsured Program reimburses providers at Medicare rates and covers additional services including but not limited to, skilled nursing facilities, long-term acute care, durable medical equipment and home health. While AEM may cover COVID-19 testing and treatment, it is limited to medically necessary emergencies, such as acute hospitalizations.
Additional information
Other provider/patient vaccine conversation resources
- Talking points for providers
- Addressing vaccine hesitancy
- Provider discussion guide: building confidence in the Johnson & Johnson vaccine
- Provider discussion guide: building confidence in COVID-19 mRNA vaccines
- COVID-19 vaccine for preteens and teens
- COVID-19 vaccine conversations with patients
- Additional resources for healthcare providers
